spotdna.blogg.se - Novavax information

NOVAVAX INFORMATION SERIES

Package leaflets for the COVID-19 vaccines

NOVAVAX INFORMATION SERIES

In response, the immune system starts producing antibodies.Ī s used for the basic series of COVID-19 vaccinationsĪ s used for the repeat vaccination against COVID-19 vaccinations If the body encounters the SARS-COV-2 virus, the immune system recognises the spike proteins on the virus.

After vaccination, the body responds by producing antibodies against the spike protein. It also contains an adjuvant: a substance that intensifies the body’s immune response to the protein. The vaccine contains very small particles of spike protein, which have been produced in a laboratory. For more information on the vaccines visit CDC: Overview of COVID-19.

The Novavax vaccine is a protein subunit vaccine. Moderna and Novavax (Novavax is only authorized for children age 12 and older).

The immune system reacts by producing antibodies, just as it does in response to the mRNA vaccines. The vector vaccine contains an inactivated cold virus (that cannot replicate) with an instruction (code) that tells your cells to make spike proteins.

The COVID-19 vaccine made by Janssen is a vector vaccine.The immune system recognises the spike proteins as foreign substances and starts making antibodies. These are the spiky protrusions on the exterior of the coronavirus. These RNA vaccines contain a protective envelope of lipids (fat) with an instruction (code) that tells your cells to make spike proteins. The COVID-19 vaccines made by Pfizer/BioNTech and by Moderna are mRNA vaccines.Read more about these vaccines on Types of COVID-19 vaccines Note: Some COVID-19 monovalent vaccine products are expired or expiring soon.